Search research articles
Contact Us
Filters
Showing results (431-440 of 6,826) with videos related to
Page
of 683
Sort By:
Nature Reviews. Drug Discovery
|
November 30, 2019
Cracking KRAS
Asher Mullard
Nature Reviews. Drug Discovery
|
February 3, 2019
2018 FDA drug approvals
Asher Mullard
Nature Reviews. Drug Discovery
|
December 29, 2017
Sage gets an antidepressant lift
Asher Mullard
The Nebraska Medical Journal
|
November 1, 1993
A descent into the maelstrom
R Asher
Nature Reviews. Drug Discovery
|
May 15, 2025
Is the FDA's plan to phase out animal toxicity testing realistic?
Asher Mullard
Nature Reviews. Drug Discovery
|
June 18, 2024
Extracellular targeted protein degrader removes antibodies in first test in humans
Asher Mullard
Nature Reviews. Drug Discovery
|
January 14, 2026
Lilly pays US$1.2 billion for Ventyx and its oral anti-inflammatories
Asher Mullard
Nature Reviews. Drug Discovery
|
October 31, 2018
FDA approves first drug under new antibacterial and antifungal drug programme
Asher Mullard
Nature Reviews. Drug Discovery
|
November 4, 2016
Immuno-oncology drugs jostle for first-line setting
Asher Mullard
Nature Reviews. Drug Discovery
|
November 4, 2016
Symptomatic AD treatment fails in first phase III
Asher Mullard
Page
of 683
Search research articles
Search
Showing results (431-440 of 6,826) with videos related to
Sort By:
Page
of 683
Nature Reviews. Drug Discovery
|
November 30, 2019
Cracking KRAS
Asher Mullard
Nature Reviews. Drug Discovery
|
February 3, 2019
2018 FDA drug approvals
Asher Mullard
Nature Reviews. Drug Discovery
|
December 29, 2017
Sage gets an antidepressant lift
Asher Mullard
The Nebraska Medical Journal
|
November 1, 1993
A descent into the maelstrom
R Asher
Nature Reviews. Drug Discovery
|
May 15, 2025
Is the FDA's plan to phase out animal toxicity testing realistic?
Asher Mullard
Nature Reviews. Drug Discovery
|
June 18, 2024
Extracellular targeted protein degrader removes antibodies in first test in humans
Asher Mullard
Nature Reviews. Drug Discovery
|
January 14, 2026
Lilly pays US$1.2 billion for Ventyx and its oral anti-inflammatories
Asher Mullard
Nature Reviews. Drug Discovery
|
October 31, 2018
FDA approves first drug under new antibacterial and antifungal drug programme
Asher Mullard
Nature Reviews. Drug Discovery
|
November 4, 2016
Immuno-oncology drugs jostle for first-line setting
Asher Mullard
Nature Reviews. Drug Discovery
|
November 4, 2016
Symptomatic AD treatment fails in first phase III
Asher Mullard
Page
of 683